Induction of apoptosis in human pancreatic carcinoma cells by a synthetic bleomycin-like ligand

Japanese Journal of Cancer Research

Volumn 89, Issue 9, 1998, Pages 947-953

  Suginaka, Rei ^a   Izui, Reiko ^a   Inoue, Jun Ichiro ^b   Muraoka, Yasuhiko ^c   Yamaguchi, Ken ^d   Otsuka, Masami ^e   Umezawa, Kazuo ^a  

^a KEIO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c INSTITUTE OF MICROBIAL CHEMISTRY   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^e KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Apoptosis; AsPC 1 pancreatic carcinoma cells; Bleomycin; HPH 3

Indexed keywords

ACETYLCYSTEINE; BLEOMYCIN A2; BLEOMYCIN DERIVATIVE; COPPER ION; DNA; GLUTATHIONE; HISTIDINE PYRIDINE HISTIDINE 3; HYDROGEN PEROXIDE; UNCLASSIFIED DRUG; ZINC;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CONTROLLED STUDY; DNA DEGRADATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PANCREAS CARCINOMA; PRIORITY JOURNAL;

EID: 0031766397     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1998.tb00653.x     Document Type: Article

References (23)

1. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S.-I., Sameshima, M., Hase, A., Seto, Y. and Nagata, S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell, 66, 223-243 (1991).
2. Laster, S. M., Wood, J. G. and Gooding, L. R. Tumor necrosis factor can induce both apoptotic and necrotic forms of cell lysis. J. Immunol., 141, 2629-2634 (1988).
3. Martikainen, P., Kyprianou, N. and Isaacs, J. T. Effect of transforming growth factor-β1 on proliferation and death of rat prostatic cells. Endocrinology, 127, 2963-2968 (1990).
4. Simizu, S., Imoto, M. and Umezawa, K. Induction of apoptosis by erbstatin in mouse leukemia L1210 cells. Biosci. Biotechnol. Biochem., 58, 1549-1552 (1994).
5. Meydan, N., Grunberger, T., Dadi, H., Shahar, M., Arpaia, E., Lapidot, Z., Leeder, J. S., Freedman, M., Cohen, A., Gazit, A., Levitzki, A. and Roifman, C. M. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature, 379, 645-648 (1996).
6. Fath, I., Schweighoffer, F., Rey, L. Multon, M.-C., Boizian, J., Duchesne, M. and Tocque, B. Cloning of Grb2 isoform with apoptotic properties. Science, 264, 971-974 (1994).
7. Walker, P. R., Smith, C., Youdale, T., Leblanc, J., Whitfield, J. F. and Sikorska, M. Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res., 51, 1078-1085 (1991).
8. Ling, Y.-H., Priebe, W. and Perez-Soler, R. Apoptosis induced by anthracycline antibiotics in P388 parent and multidrug-resistant cells. Cancer Res., 53, 1845-1852 (1993).
9. Ormerod, M. G., O'Neill, C. F., Robertson, D. and Harrap, K. R. Cisplatin induces apoptosis in a human ovarian carcinoma cell line without concomitant internucleosomal degradation of DNA. Exp. Cell Res., 211, 231-237 (1994).
10. Hennet, T., Richter, C. and Peterhans, E. Tumour necrosis factor-α induces superoxide anion generation in mitochondria of L929 cells. Biochem. J., 289, 587-592 (1993).
11. Lafon, C., Mathieu, C., Guerrin, M., Pierre, O., Vidal, S. and Valette, A. Transforming growth factor β1-induced apoptosis in human ovarian carcinoma cells: protection by the antioxidant N-acetylcysteine and bcl-2. Cell Growth Differ., 7, 1095-1104 (1996).
12. Simizu, S., Imoto, M., Masuda, N., Takada, M. and Umezawa, K. Involvement of hydrogen peroxide production in erbstatin-induced apoptosis in human small cell lung carcinoma cells. Cancer Res., 56, 4978-4982 (1996).
13. Hockenbery, D. M., Oltvai, Z. N., Xiao-Ming, Y., Milliman, C. L. and Korsmeyer, S. J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell, 75, 241-251 (1993).
14. Umezawa, H., Takita, T., Sugiura, Y., Otsuka, M., Kobayashi, S. and Ohno, M. DNA-bleomycin interaction. Nucleotide sequence-specific binding and cleavage of DNA by bleomycin. Tetrahedron, 40, 501-509 (1984).
15. Otsuka, M., Satake, H. and Sugiura, Y. Restructuring of the bleomycin metal core. Novel oxygen-activating ligands with symmetrized structure. Tetrahedron Lett., 34, 8497-8500 (1993).
16. Otsuka, M., Fujita, M., Aoki, T., Ishii, S., Sugiura, Y., Yamamoto, T. and Inoue, J. Novel zinc chelators with dual activity in the inhibition of the KB site-binding proteins HIV-EP1 and NF-κB. J. Med. Chem., 38, 3264-3270 (1995).
17. Chen, W. H., Horoszewicz, J. S., Leong, S. S., Shimano, T., Penerante, R., Sanders, W. H., Berjian, R., Douglass, H. O., Martin, E. W. and Chu, T. M. Human pancreatic adenocarcinoma: in vitro and in vivo morphology of a new tumor line established from ascites. In Vitro, 18, 24-34 (1982).
18. Sausville, E. A., Peisach, J. and Horwitz, S. B. A role for ferrous ion and oxygen in the degradation of DNA by bleomycin. Biochem. Biophvs. Res. Commun., 73, 814-822 (1976).
19. Petering, D. H., Byrnes, R. W. and Antholine, W. E. The role of redox-active metals in the mechanism of action of bleomycin. Chem. Biol. Interact., 73, 133-182 (1990).
20. Bodannes, R. S. and Chan, P. C. Ascorbic acid as a scavenger of singlet oxygen. FEBS Lett., 15, 195-196 (1979).
21. Chou, P. T. and Khan, A. U. L-Ascorbic acid quenching of singlet delta molecular oxygen in aqueous media: generalized antioxidant property of vitamin C. Biochem. Biophys. Res. Commun., 115, 932-937 (1983).
22. Marusak, R. A. and Meares, C. F. Metal-complex-catalyzed cleavage of biopolymers. In "Active Oxygen in Biochemistry," pp. 336-400 (1995). Blackie Acad. Prof., London.
23. Tounekti, O., Pron, G., Belehradek, J., Jr. and Mir, L. M. Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res., 53, 5462-5469 (1993).